[Oxaliplatin: combinations with thymidylate synthetase inhibitors: two consecutive phase II studies]

Tumori. 2001 Nov-Dec;87(6):A25-6.

[Article in Italian]

Authors

A Martoni¹, E Mini, C Pinto, A Gentile, T Mazzei

Affiliation

¹ UO di Oncologia Medica, Dipartimento di Oncologia e Ematologia, Policlinico Sant'Orsola-Malpighi, Bologna.

PMID: 11995701

No abstract available

MeSH terms

Antimetabolites, Antineoplastic / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Clinical Trials, Phase II as Topic
Colorectal Neoplasms / drug therapy*
Drug Administration Schedule
Enzyme Inhibitors / administration & dosage
Enzyme Inhibitors / therapeutic use*
Fluorouracil / administration & dosage
Humans
Organoplatinum Compounds / administration & dosage
Organoplatinum Compounds / therapeutic use*
Oxaliplatin
Quinazolines / administration & dosage
Thiophenes / administration & dosage
Thymidylate Synthase / antagonists & inhibitors*
Treatment Outcome

Substances

Antimetabolites, Antineoplastic
Enzyme Inhibitors
Organoplatinum Compounds
Quinazolines
Thiophenes
Oxaliplatin
Thymidylate Synthase
raltitrexed
Fluorouracil